Moazzam Shahzad: Haplo-HCT With PTCy Offers a Robust Alternative to MSD-HCT
Moazzam Shahzad, Assistant Professor at University of South Florida and Moffitt Cancer Center, shared a post on X about a recent article he and his colleague co-authored, published in Transplantation and Cellular Therapy, adding:
“Our latest article in Transplantation and Cellular Therapy Journal shows Haplo-HCT with PTCy delivers outcomes comparable to MSD-HCT, supporting its use as a robust alternative when a matched sibling donor is unavailable.”
Al-Ola Abdallah, Associate Professor Of Medicine at University of Kansas Medical Center, Board Member of Kansas Society of Clinical Oncology, shared Moazzam Shahzad‘s post on X:
“I’ve said it before, and I’ll say it again:
Muhammad Umair Mushtaq and Moazzam Shahzad could build an entire cancer center and run all its clinical trials by themselves!
These two are unstoppable machines!”
Title: Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Tahereh Rostami, Muhammad Kashif Amin, Shayan Forghani, Hediyeh Alemi, Naghmeh Khavandgar, Shah Rukh, Khalid Halahleh, Anurag K. Singh, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Stay updated on all scientific advnaces with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis